Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers-Reference-Cited by-同舟云学术

Immunological monitoring during therapeutic vaccination as a prerequisite for the design of new effective therapies: induction of a vaccine-specific CD4+ T-cell proliferative response in chronic hepatitis B carriers

Published:2002-10 Issue:29-30 Volume:20 Page:3598-3612
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Jung Maria-Christina,Grüner Norbert,Zachoval Reinhart,Schraut Winfried,Gerlach Tilman,Diepolder Helmut,Schirren Carl-Albrecht,Page Mark,Bailey John,Birtles Emma,Whitehead Eve,Trojan Jörg,Zeuzem Stefan,Pape Gerd R

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference17 articles.

1. Interferon in the management of chronic hepatitis B;Perrillo;Dig. Dis. Sci.,1993

2. Chisari FV. The immunobiology of viral hepatitis: T-lymphocytes in the liver. In: Crispe IN, editor. Immunobiology, Pathology, and Host Defense; 1999. p. 117–38.

3. Vaccination against hepatitis B virus: an efficient immunotherapy against hepatitis B multiplication;Pol;C R Acad. Sci. III,1993

4. Specific vaccine therapy in chronic hepatitis infection;Pol;Lancet,1994

5. T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice;Jones;Vaccine,1999

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of therapeutic vaccines for the treatment of chronic hepatitis B: A systematic review and meta-analysis of randomized controlled trials update;Medicine;2024-08-30

2. Efficient stabilization of therapeutic hepatitis B vaccine components by amino-acid formulation maintains its potential to break immune tolerance;JHEP Reports;2023-02

3. Efficacy and safety of a nanoparticle therapeutic vaccine in patients with chronic hepatitis B: A randomized clinical trial;Hepatology;2021-12-08

4. New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies;Best Practice & Research Clinical Gastroenterology;2017-06

5. Interferon-γ facilitates hepatic antiviral T cell retention for the maintenance of liver-induced systemic tolerance;Journal of Experimental Medicine;2016-05-02